These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17503125)

  • 1. Cognitive screening in multiple sclerosis.
    Scherer P
    J Neurol; 2007 May; 254 Suppl 2():II26-9. PubMed ID: 17503125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.
    Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L
    Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
    Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
    Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire.
    Akbar N; Honarmand K; Kou N; Levine B; Rector N; Feinstein A
    Mult Scler; 2010 Dec; 16(12):1500-6. PubMed ID: 20813773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
    Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
    Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive assessment in MS.
    Langdon D
    Neurodegener Dis Manag; 2015; 5(6 Suppl):43-5. PubMed ID: 26611272
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive functioning in children with multiple sclerosis.
    Montiel-Nava C; Peña JA; González-Pernía S; Mora-La Cruz E
    Mult Scler; 2009 Feb; 15(2):266-8. PubMed ID: 18922833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of cognitive impairment in multiple sclerosis: a review of current evidence.
    Amato MP; Zipoli V
    Int MS J; 2003 Aug; 10(3):72-83. PubMed ID: 14561373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
    Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH
    Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
    Hansen S; Muenssinger J; Kronhofmann S; Lautenbacher S; Oschmann P; Keune PM
    BMC Neurol; 2015 Nov; 15():246. PubMed ID: 26612613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive functioning in multiple sclerosis.
    Julian LJ
    Neurol Clin; 2011 May; 29(2):507-25. PubMed ID: 21439456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychological profile of multiple sclerosis].
    Arango-Lasprilla JC; DeLuca J; Chiaravalloti N
    Psicothema; 2007 Feb; 19(1):1-6. PubMed ID: 17295976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
    Dusankova JB; Kalincik T; Havrdova E; Benedict RH
    Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostics of cognitive dysfunctions in multiple sclerosis.
    Engel C; Greim B; Zettl UK
    J Neurol; 2007 May; 254 Suppl 2():II30-4. PubMed ID: 17503126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
    Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
    Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.